Sana Biotechnology strength attributed to EMJ Capital long call

Shares of Sana Biotechnology (SANA) are up $1.28, or 29% to $5.73 in afternoon trading after EMJ Capital’s Eric Jackson revealed in a post to X earlier that he is long the stock. In a series of posts, the investor wrote: “I’m long $SANA. The science is working, the market is turning, and the upside math checks out. This is what it looks like when a platform transitions from promise to proof… $SANA path to $100 B = 1 Type 1 Diabetes human durability w/out immunosuppression 2 GMP master cell bank + safety switch 3 Industrial-scale manufacturing 4 Expansion to autoimmune + organ-repair markets”